A Modern Ethnomedicinal Technique for Transformation, Prevention and Treatment of Human Malignant Gliomas Tumors into Human Benign Gliomas Tumors under Synchrotron Radiation

Alireza Heidari*

Faculty of Chemistry, California South University, 14731 Comet St. Irvine, CA 92604, USA

*Corresponding Author:
Heidari A
Faculty of Chemistry
California South University
14731 Comet St. Irvine, CA 92604, USA.
Tel: +1-775-410-4974
E-mail: [email protected]

Received date: July 27, 2017; Accepted date: August 02, 2017; Published date: August 07, 2017

Citation: Heidari A (2017) A Modern Ethnomedicinal Technique for Transformation, Prevention and Treatment of Human Malignant Gliomas Tumors into Human Benign Gliomas Tumors under Synchrotron Radiation. Vol. 4 No. 1:10

Visit for more related articles at American Journal of Ethnomedicine

Human cells and tissues of malignant gliomas tumors deceive our immune system so effectively that it starts working for them. But who lives by the sword, dies by the sword. Researchers show how to deceive human tumors and change human malignant gliomas into human gliomas benign forms under synchrotron radiation [1-23]. This editorial will deal with characteristic and historical aspects of ethnomedicinal technique for transformation, prevention and treatment of human malignant gliomas tumors into human benign gliomas tumors under synchrotron radiation, major challenges at present and ideas/prospective for the future. It will include the synthesis of major bulk and fine biochemical, pharmaceuticals, pharmacological, medical, medicinal, clinical and biological oncology. In this regard, the researchers in depollution and in biomass uses derived chemicals and pharmaceuticals [24-34]. Particular emphasis will be pot on activation and selective oxidation of simple and complex human malignant gliomas tumors into human benign gliomas tumors under synchrotron radiation, heterogeneous catalysis for fine chemicals, asymmetric catalysis, environment and biomass catalysis, high throughout researches for combinational catalysis and projection for catalysis in the twenty first century [35-75].

Case studies have been chosen to exemplify the different fields of interest. The case of simple and complex human malignant gliomas tumors selective oxidation to the corresponding into human benign gliomas tumors under synchrotron radiation will be presented such as the up- grading of a modern ethnomedicinal technique for transformation, prevention and treatment of human malignant gliomas tumors into human benign gliomas tumors under synchrotron radiation, which is of paramount importance for biochemical, pharmaceutical, pharmacological, medical, medicinal, clinical and biological interests, namely. In fact, researchers in this field of study around the world want to how such transform, prevent and treat human malignant gliomas tumors into human benign gliomas tumors under synchrotron radiation can be activated and up-graded. The case of human malignant gliomas tumors oxidation into human benign gliomas tumors under synchrotron radiation on HIF1α mixed oxides and on basic catalysts based on VEGF, PDGFβ, TGFα and erythropoietin will be presented. A high throughout approach for catalyst preparation will also be given. Environment catalysis for Selective Catalytic Reduction (SCR) reaction and a modern ethnomedicinal technique for transformation, prevention and treatment of human malignant gliomas tumors into human benign gliomas tumors under synchrotron radiation will be described. Finally, the process by which human cells and tissues acquire the properties of cancer will be detailed from human malignant gliomas tumors into human benign gliomas tumors under synchrotron radiation.

References

Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article